Mateo Chvatal-Medina  |  Persona

publicaciones seleccionadas

• documento

  • Humoral Response to BNT162b2 Vaccine Against SARS-CoV-2 Variants Decays After Six Months
    
  • In vitro and in silico evaluation of antiretrovirals against SARS-CoV-2: A drug repurposing approach
    
  • Integrase inhibitors: current protagonists in antiretroviral therapy
    
  • Neutralizing antibody titers to Omicron six months after vaccination with BNT162b2 in Colombia